Literature DB >> 10667039

Chylothorax.

H G de Beer1, M J Mol, J P Janssen.   

Abstract

Chylothorax is defined as an accumulation of chyle in the pleural space caused by disruption of the thoracic duct or one of its major divisions. Chyle has a high content of triglycerides. The odorless fluid is turbid and milky due to the presence of fat containing particles, the chylomicrons. The etiology of chylothorax can be divided into four major categories: tumor, trauma, idiopathic and miscellaneous. Although chylothorax is uncommon, it is a serious and potentially hazardous disorder. Loss of chyle leads to metabolic disturbances, malnutrition and immunodeficiency. Treatment consists of treatment of the underlying disease, conservative treatment (medium chain triglyceride diet, parenteral nutrition) or surgical intervention. Appropriate timing of surgical intervention is essential. Since the ligation of the thoracic duct can be performed during thoracoscopy, this minimal interventional technique is the procedure of choice when conservative treatment fails.

Entities:  

Mesh:

Year:  2000        PMID: 10667039     DOI: 10.1016/s0300-2977(99)00114-x

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  10 in total

1.  Chylothorax after neck dissection for thyroid carcinomas: report of three cases.

Authors:  Wei Tian; Zhi-Yu Li; Ping Wang; Xin-Bin Lin
Journal:  Surg Today       Date:  2011-11-11       Impact factor: 2.549

2.  Chylothorax associated with thrombosis of the cranial vena cava.

Authors:  Ameet Singh; Brigitte A Brisson
Journal:  Can Vet J       Date:  2010-08       Impact factor: 1.008

3.  Conservative management of chylothorax after coronary artery bypass grafting.

Authors:  Gokalp Altun; Zerrin Pulathan; Dilek Kutanis; Dogus Hemsinli; Engin Erturk; Ali Civelek
Journal:  Tex Heart Inst J       Date:  2015-04-01

4.  Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1.

Authors:  A Ayadi; H Zheng; P Sobieszczuk; G Buchwalter; P Moerman; K Alitalo; B Wasylyk
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

5.  Chylothorax after pediatric cardiac surgery complicates short-term but not long-term outcomes-a propensity matched analysis.

Authors:  Nikoletta R Czobor; György Roth; Zsolt Prodán; Daniel J Lex; Erzsébet Sápi; László Ablonczy; Mihály Gergely; Edgar A Székely; János Gál; Andrea Székely
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

Review 6.  Chylothorax after esophagectomy for cancer: impact of the surgical approach and neoadjuvant treatment: systematic review and institutional analysis.

Authors:  Michael Kranzfelder; Ralf Gertler; Alexander Hapfelmeier; Helmut Friess; Marcus Feith
Journal:  Surg Endosc       Date:  2013-05-25       Impact factor: 4.584

7.  A modified pleurodesis in treating postoperative chylothorax.

Authors:  Yutian Lai; Xi Zheng; Yong Yuan; Tian-Peng Xie; Yong-Fan Zhao; Zi-Jiang Zhu; Yang Hu
Journal:  Ann Transl Med       Date:  2019-10

8.  Chlyous leak after radical oesophagectomy: Thoracic duct lymphangiography and embolisation (TDE)-A case report.

Authors:  M Atie; G Dunn; G L Falk
Journal:  Int J Surg Case Rep       Date:  2016-04-07

9.  A 44-year-old, Caucasian, male nonsmoker with worsening difficulty in breathing and decreased exercise tolerance.

Authors:  Sunita Rai; Alina Andreea Ionescu
Journal:  Breathe (Sheff)       Date:  2017-06

10.  Successful management of extremely high-output refractory congenital chylothorax with chemical pleurodesis using 4% povidone-iodine and propranolol: a case report.

Authors:  Kathleen Borcyk; Ammar Kamil; Kristine Hagerty; Melissa Deer; Paul Tomich; Ann L Anderson Berry
Journal:  Clin Case Rep       Date:  2018-02-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.